Aeluma, Inc. secures a $30 million letter of intent for semiconductor R&D funding under the CHIPS Act.
Quiver AI Summary
Aeluma, Inc., a semiconductor company based in Goleta, California, has announced a letter of intent for up to $30 million in funding through the CHIPS and Science Act, administered by the U.S. Department of Commerce. This funding will support the development of Aeluma's scalable non-InP semiconductor manufacturing platform for photonics, crucial for various applications including AI and advanced computing. Aeluma's technology aims to address supply chain constraints and enhance the production of high-speed photonic components. The funding will be crucial for commercializing Aeluma's innovative solutions in the semiconductor market, strengthening U.S. technology leadership and national security. Aeluma's President, Jonathan Klamkin, expressed enthusiasm for being selected to contribute to the U.S. AI ecosystem, while the Commerce Secretary emphasized the investment's potential to boost domestic capabilities and create jobs. The proposal is subject to further approvals and due diligence before finalization.
Potential Positives
- Aeluma has signed a letter of intent for up to $30 million in funding under the CHIPS and Science Act, which will support the development of its semiconductor manufacturing platform.
- The funding aims to strengthen U.S. technology leadership and enhance domestic semiconductor R&D, aligning with national security interests.
- Aeluma's scalable, non-InP substrate platform addresses supply chain constraints while advancing critical technologies for AI and advanced computing, positioning the company for potential market leadership.
- The initiative is expected to accelerate the commercialization of Aeluma's high-performance semiconductors, tapping into the growing demand for photonics in various high-growth markets.
Potential Negatives
- Dependency on receiving final approval for funding, which is contingent on due diligence and other government approvals, raises uncertainty about the actual receipt of the proposed $30 million.
- Any awarded funding may result in equity being issued to the U.S. Department of Commerce, potentially leading to dilution of existing shareholders’ equity.
- Aeluma's history of losses and limited operating history raises concerns about its ability to achieve profitability and meet future expectations related to the funding and technology commercialization.
FAQ
What is the recent funding announcement by Aeluma, Inc.?
Aeluma has signed a letter of intent for up to $30 million under the CHIPS and Science Act for semiconductor R&D.
How will the funding benefit Aeluma's technology?
The funding will support the development of Aeluma's scalable, non-InP semiconductor manufacturing platform, crucial for photonics technology.
What are the applications of Aeluma's technology?
Aeluma's technology is applied in mobile, AI, defense, aerospace, robotics, automotive, AR/VR, and quantum sectors.
Who administers the CHIPS and Science Act funding?
The funding is administered by the U.S. Department of Commerce to enhance domestic semiconductor R&D and technology leadership.
What are the implications of this funding for U.S. national security?
This funding aims to strengthen domestic semiconductor manufacturing and supply chain resiliency, enhancing national security capabilities.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ALMU Insider Trading Activity
$ALMU insiders have traded $ALMU stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $ALMU stock by insiders over the last 6 months:
- JONATHAN KLAMKIN (Chief Executive Officer) has made 0 purchases and 11 sales selling 110,000 shares for an estimated $2,164,482.
- MARK N. TOMPKINS has made 0 purchases and 7 sales selling 129,500 shares for an estimated $2,042,237.
- STEVEN DENBAARS has made 0 purchases and 6 sales selling 50,000 shares for an estimated $923,490.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ALMU Revenue
$ALMU had revenues of $1.2M in Q3 2026. This is a decrease of -2.63% from the same period in the prior year.
You can track ALMU financials on Quiver Quantitative's ALMU stock page.
You can access data on ALMU stock through the Quiver Quantitative API.
$ALMU Hedge Fund Activity
We have seen 47 institutional investors add shares of $ALMU stock to their portfolio, and 28 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 251,105 shares (+170.6%) to their portfolio in Q1 2026, for an estimated $3,286,964
- RAYMOND JAMES FINANCIAL INC added 247,844 shares (+1256.3%) to their portfolio in Q1 2026, for an estimated $3,244,277
- MARSHALL WACE, LLP added 149,437 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,956,130
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 87,848 shares (-63.9%) from their portfolio in Q1 2026, for an estimated $1,149,930
- MAYTREE ASSET MANAGEMENT LTD added 73,473 shares (+inf%) to their portfolio in Q1 2026, for an estimated $961,761
- UBS GROUP AG added 71,868 shares (+146.2%) to their portfolio in Q1 2026, for an estimated $940,752
- WEDBUSH SECURITIES INC added 51,425 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,135,464
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
GOLETA, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, today announced that it has signed a letter of intent (LOI) for up to $30 million of proposed funding under the CHIPS and Science Act, which is administered by the U.S. Department of Commerce. The award will support Research & Development of Aeluma’s scalable, non-InP semiconductor manufacturing platform for photonics, an important technology for the U.S. economy and national security.
CHIPS funding is designed to advance semiconductor R&D, strengthen U.S. technology leadership, and accelerate the pace of commercialization to enable technology dominance in the industries of the future. Scalable manufacturing of compound semiconductors is critical to AI, advanced computing, and other applications. Aeluma’s non-InP, large-diameter substrate platform addresses supply chain constraints and enables the scaling of photonic components such as high-speed photodetectors and lasers. These technologies will accelerate domestic production for next generation AI interconnects, network communications, and sensing.
“We are pleased to be one of the companies selected to receive an LOI for funding to support the AI and advanced computing ecosystem in the U.S.,” said Jonathan Klamkin, Ph.D., Aeluma’s President and CEO. “This award aims to accelerate development and commercialization of our scalable, high-performance semiconductor platform, leveraging Aeluma’s facilities in Goleta, California, and partner sites within the U.S. With growing demand for photonics in AI and advanced computing infrastructure, Aeluma is poised for broad market adoption of our innovative technology solutions.”
“With today’s compute supply chain investments, the Trump Administration is accelerating America’s innovation engine,” said Secretary of Commerce Howard Lutnick. “These strategic investments will enhance our country’s domestic capabilities, create high-paying jobs and keep America at the forefront of the semiconductor industry.”
“The CHIPS R&D incentives will support a breakthrough in manufacturing of photonic devices for compute and communication networks,” said Bill Frauenhofer, the Executive Director for Semiconductor Innovation and Investment at the Department of Commerce. “Accelerating R&D for next generation substrates for domestic photonic devices provides American industry the extreme bandwidth and energy efficiency to scale complex AI workloads.”
Aeluma pioneered a platform to build high-performance photonics on large-diameter, mismatched substrates up to 300mm in size. This game-changing technology bridges compound semiconductor materials with mainstream microelectronics to meet the scaling requirements of high growth markets. The funded initiatives would accelerate commercialization of Aeluma’s high-performance semiconductors for the AI and advanced computing markets. InP substrates are used for manufacturing critical photonic components, but these substrates are relatively expensive, limited in manufacturing throughput, and subject to geopolitics and supply shortages. Aeluma leverages alternative, larger diameter substrates to build high-performance photonics. The development contemplated in the LOI emphasizes manufacturing readiness and scaling of Aeluma’s non-InP photonics, aligning with the U.S. CHIPS and Science Act objectives to strengthen domestic semiconductor manufacturing, supply chain resiliency, and national security.
The award is subject to the completion of further due diligence, required approvals, including internal approvals of the U.S. Government, and the parties’ execution of definitive award documents. The LOI contemplates a portion of the award being funded up front and the remainder funded on a milestone-based award structure tied to eligible project costs and technical progress.
Any securities issued to the U.S. Department of Commerce in connection with the proposed award will not be registered under the Securities Act of 1933, as amended, and may be issued only pursuant to an applicable exemption from the registration requirements of that Act. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities of Aeluma, nor shall there be any sale of such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. In connection with executing final award documents, Aeluma would issue equity securities to the U.S. Department of Commerce with an aggregate value equal to the award amount.
About Aeluma
Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test, and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com .
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other securities laws. All statements in this press release that are not historical are forward-looking statements, including, among other things, statements whether Aeluma or the U.S. Department of Commerce will enter into definitive award documents on acceptable terms, or at all, whether Aeluma will receive or retain any portion of the proposed funding, the potential issuance of Company securities to the U.S. Department of Commerce, potential applications and resulting benefits of Aeluma’s technology, timing of development and commercialization of Aeluma’s products, anticipated demand for Aeluma’s products, and impacts of the Award on the same. These statements are not historical facts but rather are based on Aeluma’s current expectations, estimates, and projections regarding its business, operations, and other similar or related factors. Words such as “anticipate,” “could,” “growing,” “intend,” “may,” “plan,” “poised,” “potential,” “will,” “would,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. These forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Aeluma’s control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including uncertainty as to whether Aeluma and the U.S. Department of Commerce will establish and execute definitive award documents for the proposed funding on acceptable terms, or at all; uncertainty as to whether, when, and in what amount Aeluma will receive or retain any portion of the proposed funding; the perceived and actual dilutive effects of the proposed issuance of common stock; impacts of an equity stake by the U.S. government in Aeluma, including any related reputational, regulatory, or governance considerations; Aeluma’s ability to satisfy applicable milestones associated with the funding; the risk that anticipated benefits of the proposed funding, including acceleration of commercialization and scaling of Aeluma’s non-InP photonics platform, may not be realized on the timeline anticipated or at all; changes in U.S. government policy, funding priorities, or budgetary constraints that could affect the availability or continuation of CHIPS and Science Act programs; Aeluma’s history of losses and limited operating history, and its ability to achieve or sustain profitability; competitive, technological, and market risks affecting the adoption of Aeluma’s semiconductor and photonics products for AI, high-performance computing, and other target markets; general economic, geopolitical, and supply-chain conditions affecting the semiconductor industry; and other risks described in Aeluma’s filings with the U.S. Securities and Exchange Commission. Aeluma undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available, except as required by law.
Company:
Aeluma, Inc.
(805) 351-2707
[email protected]
Investor Contact:
Financial Profiles, Inc.
Moira Conlon and Alex Villalta
(310) 622-8227
[email protected]